Key result
Extreme admission pulse pressure linked to ~18-fold higher cardiac death risk in post-PCI ACS patients.
Why the study?
To evaluate admission pulse pressure as an independent predictor of 12-month mortality in ACS patients undergoing PCI, and explore its joint effect with LVEF.
Does admission pulse pressure and its interaction with LVEF predict 12-month mortality in ACS patients undergoing PCI?
Observational (n=2,213)
Does admission pulse pressure and its interaction with LVEF predict 12-month mortality in ACS patients undergoing PCI?
Answers are grounded in this paper and cite their sources.
Admission pulse pressure exhibits a U-shaped association with 12-month mortality in ACS patients post-PCI, with extreme values (≤40 mmHg or >80 mmHg) significantly increasing the risk of cardiac death, especially in those with reduced LVEF.
AIM To evaluate admission pulse pressure (PP) as an independent predictor of 12-month mortality in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), and to explore its joint effect with left ventricular ejection fraction (LVEF). METHODS This observational study analyzed 2213 consecutive ACS patients from the BIPass study who underwent PCI. Patients were stratified by LVEF (>50% vs. ≤50%) and PP levels (≤ 40 mmHg, 40 < PP ≤ 60 mmHg, 60 < PP ≤ 80 mmHg, and > 80 mmHg). Primary endpoint was cardiac death, secondary endpoint was 12-month all-cause death. Restricted cubic spline (RCS) and Cox models assessed PP-mortality associations after adjusting for confounders; PP-LVEF interaction was visualized via heatmap and 3D surface plot. RESULTS During follow-up, 37 all-cause deaths (1.67%) and 22 cardiac deaths (0.99%) were recorded. RCS confirmed a U-shaped PP-12-month mortality association (lowest risk: 41-60 mmHg). Multivariable analysis showed low PP (≤ 40 mmHg; adjusted HR = 18.21, 95% CI:1.65-201.01, P = 0.018) and high PP (> 80 mmHg; adjusted HR = 18.91, 95% CI:2.05-174.93, P = 0.010) independently predicted cardiac death. In LVEF ≤50% patients, extreme PP elevated cardiac death (P = 0.004) and all-cause death (P = 0.044); in LVEF >50% patients, only high PP increased outcomes (cardiac death: P = 0.034; all-cause death: P = 0.028), with low PP showing no significance . CONCLUSIONS Admission PP has a U-shaped association with 12-month mortality in post-PCI ACS patients. Reduced LVEF amplifies extreme PP's adverse effects. Integrated PP-LVEF assessment enhances risk stratification and guides personalized management.
No takes yet. Share an insight, caveat, or question.
De et al. (2026) conducted an observational in Acute coronary syndrome (ACS) (n=2,213). Admission pulse pressure (PP) vs. PP 41-60 mmHg was evaluated on Cardiac death (HR 18.21 (low PP) / HR 18.91 (high PP), 95% CI 1.65-201.01 (low PP) / 2.05-174.93 (high PP), p=0.018 (low PP) / 0.010 (high PP)). Admission pulse pressure showed a U-shaped association with 12-month cardiac death in post-PCI ACS patients, with both low and high PP predicting mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: